Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 238

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 238
---
 or the underlying business analysis related to the Business Combination. As described above, BofA declined to serve in any capacity in connection with the Business Combination with the Company and agreed to waive its deferred compensation relating to the IPO in connection with the Business Combination with the Company. Accordingly, BofA has not been involved in the Business Combination with the Company, the preparation of any disclosure that is included in this proxy statement/prospectus, or any business analysis underlying such disclosure, and shareholders do not have the benefit of any such involvement. Shareholders and investors should not place any reliance on the fact that BofA was previously involved in the IPO. 98 Unaudited Pro Forma Combined Financial Information Introduction OmnigenicsAI is providing the following unaudited pro forma combined financial information to aid you in your analysis of the financial aspects of the Transactions. The following unaudited pro forma combined statements of financial position as of December 31, 2024, combines the historical audited balance sheet of APx as of December 31, 2024 and the historical unaudited combined statement of financial position of the Company as of December 31, 2024, giving pro forma effect to the Business Combination, as of December 31, 2024. The following unaudited pro forma combined statements of operations for the six -monthperiod ended December31, 2024, combine: •the historical unaudited combined statement of operations of OmnigenicsAI for the six -monthperiod ended December31, 2024; and •the historical statement of operations of APx for the six -monthperiod ended December31, 2024, using its audited statement of operations for the fiscal year ended December31, 2024, deducting its unaudited statement of operations for the six -monthperiod ended June30, 2024. The following unaudited pro forma condensed combined statements of operations for the year ended June 30, 2024, combine: •the historical audited combined statement of operations of OmnigenicsAI for year ended June30, 2024; and •the historical statement of operations of APx for the twelve -monthperiod ended June30, 2024 using its unaudited consolidated statements of operations for the six -monthperiod ended June30, 2024, added with its audited consolidated statements of operations for the fiscal year ended December31, 2023, deducting its unaudited consolidated statements of operations for the six -monthperiod ended